drugset / Trial / NCT00655993

Effect of Statin Therapy on C-reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)

NCT00655993

Phase 1 Completed 30 enrolled VA Loma Linda Health Care System
RandomizedCrossoverQuadruple-blindTreatment

Summary

Hypothesis for this pilot study is that simvastatin will lower the levels of CRP and ET-1 in COPD patients.

Timeline

Start
2008-04
Primary completion
2009-03
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Simvastatin Small molecule 40 mg Oral